This week I’m posting another interview that took place at ASH 2016 with Dr. Adrian Wiestener from the NIH where we discussed ibrutinib failure as a result of progressive CLL or Richter’s Transformation. You can view my summary, and watch the interview here.
We have posted interviews and articles about research that is being conducted to study treatment options for patients with relapsed or refractory CLL. On occasion we will make our readers of a clinical trial that is starting that might be of interest. Today we have posted some information about a trial for patients with relapsed refractory CLL who have received 2 or more prior treatments, including treatment with a BTK inhibitor such as ibrutinib or acalabrutinib. You can read more about it here.
CLL Patient Support Group Meetings This Week
Tuesday, June 20th at 6 PM in Tampa, FL – The Central Florida CLL Support Group, sponsored by the CLL Society will be meeting. More information here.
Saturday, June 24th at 10 AM in Belmont, NC – The Charlotte-area CLL Support Group, sponsored by the CLL Society will be meeting. More information here.
Saturday, June 24th at 1 PM in Dedham, MA – The Boston-area CLL Support Group, sponsored by the CLL Society will be meeting. More information here.
Tuesday, June 27th at 7 PM in Berea, OH – The Northeast Ohio CLL Support Group, sponsored by the CLL Society will be meeting. More information here.
ALSO – We are actively forming CLL-specific support groups in a number of cities around the country. To see if your city is one of them, click here and select the interest survey for your city. Not listed, but interested in starting one? Email us at firstname.lastname@example.org Thanks!
CLL Patient Education Meetings
Wednesday, June 28th from 6:30 PM to 8:00 PM in Los Angeles, CA– The Leukemia and Lymphoma Society invites you to attend a FREE dinner meeting: Chronic Lymphocytic Leukemia (CLL): Recent Advances in Treatment and Updates from the International Workshop on CLL at UCLA featuring Herbert Eradat, MD, MS. Pre-registration is required. Find out more information and register here.
In the meantime….
We are all in this together.
Brian Koffman, MD